Aspo Plc ANNOUNCEMENT 18.11.2025 Aspo Plc: Share repurchase 18.11.2025 In the Helsinki Stock Exchange Trade date 18.11.2025 Bourse trade Buy Share ASPO Amount 3 500Shares Average price/ share 6,7486EUR Total cost <td style="width:114.67px;;text-align: left ; vertical-align: m ...

Core Viewpoint - Element Fleet Management Corp. has received approval from the Toronto Stock Exchange to renew its normal course issuer bid (NCIB) for repurchasing its common shares as part of its capital return strategy [2][3]. Group 1: NCIB Details - The approved NCIB allows the company to purchase up to 39,930,568 common shares, which is approximately 10% of the public float, from November 20, 2025, to November 19, 2026, or until the purchases are completed [3]. - The average daily trading volume of the common shares was 586,717, limiting daily purchases under the NCIB to 146,679 shares, excluding block purchases [4]. - The company plans to fund the NCIB using existing cash resources, and any repurchased shares will be cancelled [5]. Group 2: Previous NCIB Performance - Under the current NCIB that started on November 20, 2024, the company has repurchased 4,806,957 common shares at an average price of CAD 31.32 per share as of November 10, 2025 [6]. Group 3: Automatic Securities Purchase Plan (ASPP) - The company will implement an automatic securities purchase plan (ASPP) with an independent broker to facilitate share repurchases during blackout periods [8]. - The ASPP will allow the broker to purchase shares at times when the company cannot, based on parameters set by the company prior to the blackout period [8]. - The ASPP will terminate when the purchase limit is reached, the NCIB is completed, or the company decides to terminate it [9]. Group 4: Company Overview - Element Fleet Management is the largest publicly traded pure-play automotive fleet manager globally, providing comprehensive fleet management services across various regions [10].

Core Viewpoint - Goodfellow Inc. has received approval from the Toronto Stock Exchange to renew its normal course issuer bid (NCIB) for its common shares, allowing the company to repurchase up to 481,002 shares over a 12-month period [1][2]. Group 1: NCIB Details - The NCIB will commence on November 20, 2025, and end no later than November 19, 2026, allowing the company to buy back approximately 10% of its public float [2]. - As of November 6, 2025, Goodfellow had 8,350,054 shares issued and outstanding, with a public float of 4,810,022 shares [2]. - All shares purchased under the NCIB will be acquired on the open market at prevailing market prices, and the company may also seek exemptions for private agreements [3]. Group 2: Trading Volume and Purchase Limits - The average daily trading volume of Goodfellow shares on the TSX for the six months ending October 31, 2025, was 2,895 shares [4]. - Daily purchases under the NCIB will be limited to 1,000 shares, with exceptions for weekly block purchases not owned by insiders [4]. Group 3: Financial Strategy - Goodfellow views the acquisition of shares for cancellation as a prudent use of its funds, with decisions on the number and timing of purchases based on market conditions and the company's financial position [5]. - The company has renewed its automatic share purchase plan (ASPP) to facilitate share repurchases during regulatory restrictions or blackout periods [6]. Group 4: Previous NCIB Performance - Under the current NCIB, which expires on November 19, 2025, Goodfellow had approval to purchase up to 493,102 shares and had repurchased 111,100 shares at an average price of $12.1781 per share as of November 6, 2025 [8]. Group 5: Company Overview - Goodfellow Inc. is a diversified manufacturer of value-added lumber products and a wholesale distributor of building materials and floor coverings, serving both commercial and residential sectors across Canada and the Northeastern U.S. [9].

Regeneron Pharmaceuticals Conference Call Summary Company Overview - **Company**: Regeneron Pharmaceuticals (NasdaqGS:REGN) - **Event**: 2025 Conference on November 17, 2025 Key Industry Insights - **Eylea Performance**: - High-dose Eylea (Eylea HD) has shown significant growth with demand increasing by 5% in Q1, 16% in Q2, and 18% in Q3 [4][5][6] - Anticipated growth for Q4 is expected to moderate to high single digits due to competitive market pressures [5] - The competitive landscape includes pricing pressures, with an 8% price impact noted in Q3 [9] - **Market Dynamics**: - Regeneron is focused on differentiating Eylea through real-world efficacy and durability, which is resonating with physicians [4] - The company is addressing reimbursement confidence among physicians to ensure continued prescribing of Eylea HD [5][6] - **Patient Assistance Programs**: - Regeneron has instituted a matching program to support patient assistance organizations, aiming to match contributions up to $200 million, but has seen disappointing participation [12][13] - Concerns exist regarding the impact of patients not receiving supplemental insurance, with an expected 10% impact on patient access [11] Product Development and Regulatory Updates - **Label Enhancements**: - Regeneron is working on label enhancements for Eylea HD, with a PDUFA date later this month for RVO and Q4 dosing [18][19] - The company is optimistic about potential approvals by year-end, contingent on successful inspections of alternative fillers [19][20] - **Pipeline and Future Opportunities**: - Regeneron is exploring opportunities in obesity treatments, including the Hanmi GLP-1 asset, which could be a significant player in the market [31][32] - The company is also investigating Myostatin and its potential applications in obesity and related comorbidities [35][37] Financial Strategy and Shareholder Value - **Capital Deployment**: - Regeneron emphasizes investing in internal capabilities and expanding manufacturing, with a $2 billion investment in New York State [26][27] - The company has a share repurchase program and initiated a dividend program earlier this year [27] - **Cash Management**: - Regeneron is focused on deploying cash effectively to enhance shareholder value, with a cautious approach to accumulating excessive cash reserves [30] Conclusion - Regeneron Pharmaceuticals is navigating a competitive landscape with Eylea while focusing on patient access and assistance programs. The company is actively pursuing label enhancements and exploring new market opportunities in obesity treatments. Financially, Regeneron is committed to strategic investments and maintaining shareholder value through capital deployment and cash management strategies.

Core Insights - Assurant, Inc. (AIZ) has announced a significant increase in its common stock dividend, reflecting its strong financial position and commitment to shareholder returns [1][2] - The quarterly dividend has been raised to 88 cents per share from 80 cents, marking a 10% increase and the 21st consecutive year of dividend growth [2][10] - The new dividend yield based on the stock's closing price of $227.05 is 1.41%, making it appealing for yield-seeking investors [3][10] Financial Strength and Capital Management - Assurant's strategy includes returning excess cash to shareholders through both dividend increases and share repurchases, demonstrating solid capital position and cash generation capabilities [5][10] - As of September 30, 2025, liquidity stood at $613 million, significantly above the targeted minimum of $225 million, with $206.3 million spent on share repurchases in the first nine months of 2025 [6][10] - The company plans to return up to $300 million to shareholders through share repurchases in 2025, indicating strong cash flow generation [7][10] Performance Metrics - Assurant's return on equity was 18.6% over the trailing 12 months, outperforming the industry average of 15.3% [8] - Year-to-date, Assurant shares have gained 6.5%, surpassing the industry growth of 6% [9]

Core Viewpoint - Saputo Inc. has received approval from the Toronto Stock Exchange to renew its normal course issuer bid (NCIB) to repurchase up to 5% of its outstanding common shares, reflecting the company's commitment to returning capital to shareholders while maintaining flexibility for growth opportunities [1][2]. Group 1: NCIB Details - Under the renewed NCIB, Saputo may purchase up to 20,498,278 common shares, which is 5% of its 409,965,571 issued shares as of November 7, 2025 [2]. - The NCIB will be effective for one year, starting November 19, 2025, and ending no later than November 18, 2026 [2]. - Daily purchases will be limited to 154,649 common shares based on the average daily trading volume of 618,596 shares over the last six months [2]. Group 2: Automatic Purchase Plan - Saputo has established an automatic purchase plan (APP) to facilitate share repurchases during self-imposed blackout periods, effective from November 19, 2025 [3]. - The APP has been pre-cleared by the TSX and will terminate alongside the NCIB [3]. Group 3: Previous NCIB Performance - Under the current NCIB that began on November 19, 2024, Saputo received approval to repurchase up to 21,217,922 common shares, of which 15,062,184 shares were purchased by November 7, 2025, at an average price of $27.39 per share, totaling $413 million [4]. Group 4: Capital Allocation Strategy - Share repurchases are part of Saputo's broader capital allocation strategy, which includes capital expenditures, dividends, and debt reduction [5]. - The company believes that repurchasing its own shares may be a responsible allocation of cash under appropriate circumstances [5]. Group 5: Company Overview - Saputo is one of the top ten dairy processors globally, producing a wide range of dairy products, including cheese and fluid milk [6]. - The company ranks among the top cheese producers in the USA and is a leading dairy processor in Canada, Australia, and Argentina [6].

Financial Data and Key Metrics Changes - For Q3 2025, revenue totaled $48 million, representing a 30% increase from Q3 2024. Gross profit rose 11% [4] - The company reported a net loss of $1.8 million, or $0.54 per share, compared to a net loss of $800,000, or $0.28 per diluted share in the same quarter last year [4] - On a non-GAAP basis, adjusted net income per share was $0.02 compared to an adjusted net loss of $0.13 per share in the prior year quarter [4] - Pro forma adjusted earnings per share were positive $0.19 versus negative $0.54 in the third quarter a year ago [5] - Adjusted EBITDA increased to $1.3 million from $800,000 in the third quarter of last year, reflecting improved operating leverage following the merger [5] Business Line Data and Key Metrics Changes - Business services revenue was $37 million, slightly up from $36.9 million the same period last year, with gross profit remaining flat at $18.6 million [8] - Building solutions revenue totaled $9.6 million, with a gross profit of $1.7 million and adjusted EBITDA of $600,000 [11] - On a pro forma basis, building solutions revenue was $21.4 million, up from $13.7 million in Q3 2024, with pro forma gross profit rising to $5.3 million [11] - Energy services revenue was $1.3 million, with gross profit of $300,000 and adjusted EBITDA of $100,000 [13] - Pro forma energy services revenue increased to $3.7 million, gross profit reached $1.5 million, and pro forma adjusted EBITDA rose to $1 million [13] Market Data and Key Metrics Changes - The broader acquisition market has contracted in 2025 compared to 2024, but the business services segment maintained profitability [6] - The building solutions segment capitalized on the rebound in commercial construction demand while managing through softness in residential markets [11] - The energy services segment achieved strong results despite a broader slowdown across the energy sector [13] Company Strategy and Development Direction - The company is operating as a diversified holding company with four divisions: building solutions, business services, energy services, and investments [3] - The strategy emphasizes expanding geographical footprint and broadening service offerings to existing and prospective clients [9] - The company is focused on operational excellence and prudent capital allocation to maximize shareholder returns [16] - A new $3 million share repurchase program has been authorized, reflecting confidence in long-term growth prospects [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the integration of the recent merger and the realization of efficiencies across shared services [14] - The company aims to achieve $2 million in synergies from the merger, with expectations to reach this run rate within six months [52] - Management noted that the current environment is characterized by low attrition rates at Fortune 500 companies, indicating a potential recovery in the market [55] Other Important Information - The company repurchased about 8% of its shares outstanding during the third quarter, demonstrating confidence in its intrinsic value [16] - The building solutions segment ended the quarter with a $20 million backlog of committed orders, indicating a healthy pipeline [12] Q&A Session Summary Question: Record performance in building solutions - Management acknowledged strong throughput from projects that were previously delayed, contributing to record performance [19] Question: Seasonal trends in revenue - Management indicated that the fourth quarter's performance is dependent on weather patterns and site readiness [20] Question: Business services revenue differences by region - Management explained that the adjusted net revenue as a percentage of sales is higher in the Americas due to significant growth and the nature of the RPO business [26] Question: Update on European market performance - Management noted a downturn in the European market but expressed optimism about future growth due to a new management team [28][31] Question: Expected synergies from the merger - Management confirmed the target of $2 million in synergies, expected to be realized within six months [52] Question: Future acquisitions and growth strategy - Management indicated a focus on adding size to existing businesses and exploring bolt-on acquisitions in existing geographies [35]

Core Insights - Star Equity Holdings, Inc. reported a significant year-over-year increase in revenue, gross profit, and Adjusted EBITDA for Q3 2025, primarily due to the merger completed on August 22, 2025 [3][6][21] - The company achieved an adjusted net income per diluted share of $0.02 in Q3 2025, a notable improvement from a loss of $0.13 in Q3 2024, indicating a turnaround in profitability [3][6] - The Building Solutions and Energy Services segments showed strong performance, with Building Solutions revenue increasing to $21.4 million on a pro forma basis, up from $13.7 million in the prior year [9][12] Financial Performance - Total revenue for Q3 2025 was $48.0 million, a 30.1% increase from Q3 2024 [6] - Gross profit for the same period was $20.6 million, reflecting a 10.9% increase year-over-year [6] - Adjusted EBITDA rose to $1.3 million compared to $0.8 million in Q3 2024, while pro forma adjusted EBITDA was $3.1 million versus $0.6 million in the prior year [6] Segment Highlights - **Building Solutions**: Revenue reached $9.6 million with a gross profit of $1.7 million; pro forma revenue was $21.4 million, up from $13.7 million in Q3 2024 [9][10] - **Business Services**: Revenue was $37.0 million, slightly up from $36.9 million in the previous year, with gross profit remaining flat at $18.6 million [11] - **Energy Services**: Revenue was $1.3 million with a gross profit of $0.3 million; pro forma revenue was $3.7 million [12] Corporate Actions - The company repurchased approximately 8% of its outstanding shares in Q3 2025 and authorized a new $3 million share repurchase program, reflecting confidence in long-term value [4][17] - As of September 30, 2025, total cash, including restricted cash, was $18.5 million [15] Future Outlook - The company is focused on driving long-term shareholder value through organic growth, disciplined capital allocation, and potential acquisitions [5] - Star Equity is evaluating acquisition opportunities that align with its diversified holding company strategy, targeting scalable and cash-generating businesses [5]

Core Viewpoint - Enova International has authorized a new share repurchase program totaling $400 million, the largest in the company's history, which reflects confidence in its business model and long-term growth prospects [2][3]. Group 1: Share Repurchase Program - The new share repurchase program will replace the existing $300 million program and will expire on June 30, 2027 [1][2]. - The repurchases will be conducted in accordance with applicable securities laws and may occur in the open market or through privately negotiated transactions [2]. Group 2: Financial Position - Enova's CFO emphasized the company's strong balance sheet and liquidity position, which provide the financial flexibility to enhance shareholder value through investments and share repurchases [2]. - The company has provided over $65 billion in loans and financing to more than 13 million customers over the past 20 years, showcasing its significant market presence [3].

Core Viewpoint - Aspo Plc has conducted a share repurchase, acquiring a total of 3,000 shares at an average price of €6.8360 per share, amounting to a total cost of €20,508.00, which increases the total shares held by the company to 13,068 [1]. Group 1 - The share repurchase took place on November 10, 2025, on the Helsinki Stock Exchange [1]. - The repurchase is in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052 [1].